cbdMD, Inc. YCBD

YCBD Company Overview

cbdMD, Inc. (NYSE American: YCBD) is a U.S.-based consumer wellness company focused on hemp-derived cannabidiol (CBD) products and related cannabinoid formulations. The company operates within the broader health, wellness, nutraceutical, and personal care industries, with product offerings spanning tinctures, gummies, capsules, topical products, sleep aids, pet wellness products, and functional mushroom formulations. cbdMD primarily generates revenue through direct-to-consumer e-commerce sales, retail distribution partnerships, and specialty health and wellness channels.

The company’s core brands include cbdMD, Paw CBD, and selected wellness-focused product extensions tied to cannabinoids and plant-based ingredients. cbdMD positions itself around broad-spectrum and THC-free hemp products, emphasizing third-party testing, consumer transparency, and premium branding within a highly fragmented CBD market. The business originated through a series of corporate restructurings and acquisitions involving Cure Based Development, Level Brands, and related entities before adopting the cbdMD corporate identity and expanding nationally following the passage of the 2018 U.S. Farm Bill, which legalized hemp cultivation under federal law.